Cargando…
ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload
Heart failure is a major cause of morbidity and mortality worldwide, and can result from pressure overload, where cardiac remodelling is characterized by cardiomyocyte hypertrophy and death, fibrosis, and inflammation. In failing hearts, transforming growth factor (TGF)β drives cardiac fibroblast (C...
Autores principales: | Rypdal, Karoline B., Olav Melleby, A., Robinson, Emma L., Li, Jia, Palmero, Sheryl, Seifert, Deborah E., Martin, Daniel, Clark, Catelyn, López, Begoña, Andreassen, Kristine, Dahl, Christen P., Sjaastad, Ivar, Tønnessen, Theis, Stokke, Mathis K., Louch, William E., González, Arantxa, Heymans, Stephane, Christensen, Geir, Apte, Suneel S., Lunde, Ida G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767913/ https://www.ncbi.nlm.nih.gov/pubmed/36539599 http://dx.doi.org/10.1038/s42003-022-04361-1 |
Ejemplares similares
-
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
por: Rypdal, Karoline B., et al.
Publicado: (2021) -
Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy
por: Rixon, Chloe, et al.
Publicado: (2022) -
The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling
por: Andenæs, Kine, et al.
Publicado: (2018) -
Inflammation and Syndecan-4 Shedding from Cardiac Cells in Ischemic and Non-Ischemic Heart Disease
por: Strand, Mari E., et al.
Publicado: (2023) -
Syndecan‐4 Protects the Heart From the Profibrotic Effects of Thrombin‐Cleaved Osteopontin
por: Herum, Kate M., et al.
Publicado: (2020)